Late Pregnancy Sample Collection Study
Launched by SPD DEVELOPMENT COMPANY LIMITED · Jul 4, 2019
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
This study will obtain daily urine samples from pregnant volunteers, from 36 weeks pregnant until birth. It is anticipated 20-40 pregnant women will be recruited to the study.
Urine samples will be delivered to SPD either via post, or by hand and form part of the SPD BioBank. All urine samples will be stored and used for research or product validation purposes.
The study will also gather information from volunteers regarding a woman's health during her pregnancy, including any bleeding, discharge, discomfort, contractions/ Braxton Hicks via the use of a daily diary.
Pregnancy outcome det...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant female in 3rd trimester of pregnancy
- Exclusion Criteria:
- • Prescribed bed-rest during third trimester or any other pregnancy
- • complication that would affect the ability to participate in the study
- • more than 38 weeks pregnant
- • Have a planned caesarean section
About Spd Development Company Limited
SPD Development Company Limited is a leading biopharmaceutical organization dedicated to advancing innovative therapies through rigorous clinical research. With a focus on developing novel treatments across various therapeutic areas, SPD Development emphasizes scientific excellence, patient safety, and regulatory compliance. By leveraging a collaborative approach, the company aims to expedite the delivery of transformative healthcare solutions while adhering to the highest standards of quality and ethics in clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bedford, Bedfordshire, United Kingdom
Patients applied
Trial Officials
Sarah Johnson
Study Director
SPD Development company Ltd.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials